A (BVZ + CAPE + RT) (N = 44) | B (CAPE + RT) (N = 46) | Total (N = 90) | ||
---|---|---|---|---|
Patients receiving adjuvant chemotherapy | ||||
No | n (%) | 10 (22.73) | 5 (10.87) | 15 (16.67) |
Yes | n (%) | 34 (77.27) | 41 (89.13) | 75 (83.33) |
Adjuvant schedule | ||||
capecitabine | n (%) | 18 (40.9) | 21 (45.65) | 39 (43.33) |
XELOX | n (%) | 10 (22.73) | 15 (32.61) | 25 (27.78 |
FOLFOX | n (%) | 6 (13.64) | 8 (17.39) | 14 (15.56) |
Oxaliplatin + Raltitrexed | n (%) | 1 (2.27) | 1 (2.17 | 2 (2.22) |
5-Fu | n (%) | – | 2 (4.34) | 2 (2.22) |